NCT07313072Active, not recruitingPhase 2
Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 9 Dec 2025
- Start date
- 1 Sept 2026
- Primary completion date
- Apr 2027
- Lead sponsor
- Hexsel Dermatology Clinic
- Diseases
- Psoriasis
- NCT number
- NCT07313072
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 10
- From 1 Sept 2026 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Initiation of systemic medication for nail psoriasis less than six months prior.
Other illness
- History of sensitivity to any components of the study product;
Who the study is looking for
- Presence of nail psoriasis in at least one fingernail or toenail;
- Patients not using systemic medication, or without adequate response to systemic medication after at least 6 months of use;
- Ability to read, understand, and sign the Informed Consent Form (ICF) and the Consent Form for Images, Presentations, and Scientific Publications.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Departamento de Pesquisa Clínicas Hexsel de Dermatologia Coordinator of this site? Confirm its status | Porto Alegre | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.